|
Report Date : |
09.07.2012 |
IDENTIFICATION DETAILS
|
Name : |
GEMINI INDÚSTRIA
DE INSUMOS FARMACÊUTICOS LTDA |
|
|
|
|
Registered Office : |
Via Primária 4d - S/Nº - Quadra 08a - Módulos I E Ii – Daia, 75133-590
- Anápolis/Go |
|
|
|
|
Country : |
Brazil |
|
|
|
|
Financials (as on) : |
31.12.2010 |
|
|
|
|
Date of Incorporation : |
23.01.2009 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacture, Import And Distribution Of Pharmaceutical Products. |
|
|
|
|
No. of Employees : |
10 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
Brazil |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
GEMINI INDÚSTRIA DE INSUMOS FARMACÊUTICOS LTDA
|
MAIN ADDRESS: |
VIA PRIMÁRIA 4D - S/Nº - QUADRA 08A - MÓDULOS I E II - DAIA |
|
ZIP CODE/CITY: |
75133-590 - ANÁPOLIS/GO |
|
|
|
|
PHONE: |
62 4014-9102 |
|
FAX: |
62 4014-9102 |
|
E-MAIL: |
purifarma@purifarma.com.br |
|
BRANCHES: |
|
NOT AVAILABLE. |
|
MAIN ACTIVITIES: |
|
MANUFACTURE, IMPORT AND DISTRIBUTION OF PHARMACEUTICAL PRODUCTS. |
|
LEGAL FORM: |
LIMITED
LIABILITY COMPANY |
|
|
|
|
INCORPORATION DATE: |
23/01/2009 |
|
REGISTER DATE: |
12/03/2009 |
|
BALANCE SHEET FILING DATE: |
31/12 |
|
TAX CONTRIBUTOR NUMBER (CNPJ): |
10.690.195/0001-00 |
|
STATE REGISTER: |
10.450.596-6 |
|
|
|
|
SHARE CAPITAL: |
R$ 3.000.000,00 |
|
BOARD OF DIRECTORS:
|
|
|
|
|
|
JÚLIO TOMIZO TANAKA |
MANAGING PARTNER |
|
VALDETE VIODRES TANAKA |
MANAGING PARTNER |
|
IVAN DA GLORIA TEIXEIRA |
ADMINISTRATIVE DIRECTOR |
|
THE ABOVE PRINCIPALS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY. |
|
SHAREHOLDERS /
PARTNERS: |
|
|
|
|
|
JÚLIO TOMIZO TANAKA |
50% |
|
VALDETE VIODRES TANAKA |
50% |
|
AFFILIATES /
SUBSIDIARIES: |
|
|
|
LEVIALE - INDÚSTRIA COSMÉTICA LTDA |
|
GENIX - INDÚSTRIA FARMACÊUTICA LTDA |
|
PURIFARMA DISTRIBUIDORA QUÍMICA E FARMACÊUTICA LTDA |
|
BISNAGO INDÚSTRIA DE EMBALAGENS LTDA |
|
J. V. T. - CONSTRUTORA E INCORPORADORA LTDA. |
|
LVA PARTICIPAÇÕES LTDA. |
|
THE SUBJECT WAS ESTABLISHED ON JANUARY 23, 2009 TO BE ENGAGED IN THE
SAID LINE OF BUSINESS AND UP TO DATE IT IS STILL OPERATING WITHIN THE GENERAL
SCENE REPORTED HEREIN. TRADE NAME "GEMINI INDÚSTRIA E COMÉRCIO LTDA". THE CONTACTS WERE MADE THROUGH THE PHONE 11 2067-5610 / FAX 11
2215-8823 AT THE COMPANY OF THE GROUP “PURIFARMA DISTRIBUIDORA QUÍMICA E
FARMACÊUTICA LTDA”. THE E-MAIL “FINANCEIRO@PURIFARMA.COM.BR” ALSO BELONGS TO
THE REFERRED COMPANY. FURTHER DETAILS ARE SO FAR NOT KNOWN. |
|
PUBLIC INFORMATION: |
|
NO DETRIMENTAL FILES WERE FOUND. |
|
(RESEARCH DATE: 05/07/2012) |
|
GENERAL BALANCE SHEETS AS OF 31/12/2010 AND 31/12/2009. |
|
(FIGURES ARE IN REAIS). |
|
ASSETS |
|
|
|
|
CURRENT: |
31/12/2010 |
31/12/2009 |
|
|
|
|
|
|
|
CASH |
95,71 |
673,67 |
|
|
BANKS |
70.721,09 |
5.586,65 |
|
|
ADVANCES |
33.232,81 |
7.474,17 |
|
|
CLIENTS |
541.528,98 |
|
|
|
INVENTORY |
1.434.306,25 |
|
|
|
RECOVERABLE TAXES |
14.869,24 |
|
|
|
|
---------------- |
---------------- |
|
|
TOTAL CURRENT ASSETS |
2.094.754,08 |
13.734,49 |
|
|
FIXED ASSETS: |
|
|
|
|
|
|
|
|
|
FIXED ASSETS |
911.083,18 |
840.005,25 |
|
|
DEFERRED |
218.664,49 |
33.348,80 |
|
|
|
---------------- |
---------------- |
|
|
TOTAL FIXED ASSETS |
1.129.747,67 |
873.354,05 |
|
|
|
================ |
================ |
|
|
TOTAL ASSETS |
3.224.501,75 |
887.088,54 |
|
|
LIABILITIES: |
|
|
|
|
CURRENT: |
31/12/2010 |
31/12/2009 |
|
|
|
|
|
|
|
SUPPLIERS |
644.223,16 |
|
|
|
SALARIES PAYABLE |
7.307,92 |
4.088,87 |
|
|
SOCIAL OBLIGATIONS |
5.214,50 |
3.667,33 |
|
|
PROVISIONS |
9.985,93 |
1.773,17 |
|
|
TAXES & CONTRIBUTIONS |
117.748,27 |
1.813,87 |
|
|
ACCOUNTS PAYABLE |
1.385,85 |
34.745,30 |
|
|
|
---------------- |
---------------- |
|
|
TOTAL CURRENT LIABILITIES |
785.865,63 |
46.088,54 |
|
|
LONG TERM
LIABILITIES: |
|
|
|
|
|
|
|
|
|
LOANS AND FINANCING |
1.434.487,07 |
|
|
|
|
---------------- |
---------------- |
|
|
TOTAL LONG TERM LIABILITIES |
1.434.487,07 |
|
|
|
NET EQUITY: |
|
|
|
|
|
|
|
|
|
SHARE CAPITAL |
3.000.000,00 |
3.000.000,00 |
|
|
UNPAID CAPITAL |
-1.929.000,00 |
-2.159.000,00 |
|
|
PROFIT (LOSS) OF PERIOD |
-66.850,94 |
|
|
|
|
---------------- |
---------------- |
|
|
TOTAL NET EQUITY |
1.004.149,06 |
841.000,00 |
|
|
|
================ |
================ |
|
|
TOTAL LIABILITIES |
3.224.501,76 |
887.088,54 |
|
|
PROFIT AND LOSS ACCOUNTS AS OF 31/12/2010 AND 31/12/2009. |
|
(FIGURES ARE IN REAIS). |
|
|
31/12/2010 |
31/12/2009 |
|
|
|
|
|
|
|
GROSS SALES |
1.742.609,70 |
|
|
|
(-) TAXES ON SALES |
243.364,18 |
|
|
|
|
---------------- |
---------------- |
|
|
NET SALES |
1.499.245,52 |
|
|
|
(-) COST OF SOLD GOODS |
1.380.437,80 |
|
|
|
|
---------------- |
---------------- |
|
|
GROSS PROFIT |
118.807,72 |
|
|
|
OPERATING REVENUE (EXPENSE) |
-145.364,33 |
|
|
|
FINANCIAL REVENUE (EXPENSE) |
16.413,98 |
|
|
|
|
---------------- |
---------------- |
|
|
OPERATIONAL PROFIT (LOSS) |
-10.142,63 |
|
|
|
CONTRIBUTION/INCOME TAX |
-56.708,31 |
|
|
|
|
---------------- |
---------------- |
|
|
NET PROFIT (LOSS) |
-66.850,94 |
|
|
|
MONTHLY SALES |
|||
|
|
2011 |
|
|
|
|
--------------------- |
|
|
|
JANUARY |
R$ 624.816,25 |
|
|
|
FEBRUARY |
R$ 673.837,70 |
|
|
|
MARCH |
R$ 991.666,42 |
|
|
|
APRIL |
R$ 1.591.818,35 |
|
|
|
MAY |
R$ 1.251.985,63 |
|
|
|
JUNE |
R$ 1.045.368,64 |
|
|
|
JULY |
R$ 1.304.476,33 |
|
|
|
AUGUST |
R$ 2.151.590,47 |
|
|
|
SEPTEMBER |
R$ 1.644.324,22 |
|
|
|
OCTOBER |
R$ 1.650.710,82 |
|
|
|
NOVEMBER |
R$ 2.387.723,28 |
|
|
|
DECEMBER |
R$ 1.728.951,11 |
|
|
|
TOTAL |
R$ 17.047.269,22 |
|
|
|
RATIOS: |
31/12/2010 |
31/12/2009 |
|
|
QUICK RATIO |
,84 |
|
,30 |
|
|
|
|
CURRENT RATIO |
2,67 |
|
,30 |
|
|
|
|
ACCOUNTS RECEIVABLE TURNOVER |
2,77 |
TIMES |
|
|
|
|
|
DAYS' SALES IN RECEIVABLES |
130,03 |
DAYS |
|
|
|
|
|
INVENTORY TURNOVER |
,96 |
TIMES |
|
|
|
|
|
ACCOUNTS PAYABLE PERIOD |
168,00 |
DAYS |
|
|
|
|
|
RETURN ON ASSETS |
,47 |
TIMES |
|
|
|
|
|
SALES TURNOVER ON NET EQUITY |
1,49 |
TIMES |
|
|
|
|
|
NET WORTH TIE-UP |
,91 |
|
1,00 |
|
|
|
|
INDEBTEDNESS |
2,21 |
|
,05 |
|
|
|
|
EQUITY RATIO |
31,14 |
% |
94,80 |
% |
|
|
|
WORKING CAPITAL RATIO |
166,55 |
% |
-70,20 |
% |
|
|
|
GENERAL SOLVENCY |
1,45 |
|
19,25 |
|
|
|
|
RETURN ON NET EQUITY |
-6,66 |
% |
|
|
|
|
|
RETURN ON SALES (PROFIT MARGIN) |
-4,46 |
% |
|
|
|
|
|
GROSS PROFIT MARGIN |
7,92 |
% |
|
|
|
|
|
OPERATIONAL RESULT |
-,68 |
% |
|
|
|
|
|
SALES TURNOVER ON LIABILITIES |
1,91 |
TIMES |
|
|
|
|
|
FOREIGN CURRENCY ON ASSETS |
|
|
|
|
|
|
|
FOREIGN CURRENCY ON LIABILITIES |
|
|
|
|
|
|
|
EXCHANGE RATE: |
|
|
US$ 1,00 = R$ 2,02 |
- OFFICIAL RATE ON 04/07/2012 |
|
US$ 1,00 = R$ 1,66 |
- OFFICIAL RATE ON 31/12/2010 |
|
US$ 1,00 = R$ 1,74 |
- OFFICIAL RATE ON 31/12/2009 |
|
COMMENTS ON THE
FINANCIAL INFORMATION: |
|
FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS. THE FIGURES AVAILABLE SHOW A DELICATE FINANCIAL STANDING. THE LEVEL OF
INDEBTEDNESS IS LOW AND IT IS NOTED GOOD CURRENT RATIO AND POSITIVE WORKING
CAPITAL. IN ADDITION IT ALREADY SHOWS AN INTERESTING SALES VOLUME BUT
NEGATIVE RESULT WAS MADE. REMARKS: THE 2009 PROFIT AND LOSS ACCOUNT IS NOT AVAILABLE DUE TO THE FACT THAT
THE COMPANY STARTED ITS OPERATIONS IN 2010 ONLY. THE PREVIOUS UNPAID CAPITAL WAS ADJUSTED AS IT WAS AN INTERIM BALANCE
SHEET. THE CORRECT ONE IS STATED AT THE 2010 BALANCE SHEET. |
|
REAL ESTATE: |
OWNED PREMISES ARE VALUED AT R$ 890.781,51
|
VEHICLES: |
NOT AVAILABLE.
|
MACHINES: |
NOT AVAILABLE.
|
NOT AVAILABLE. |
|
|
BRANCH/PHONE: |
|
BANCO DO BRASIL S/A |
3388-X / 62 3311-1633 |
|
REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION
OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE
ARE UNABLE TO PROVIDE ANY BANKING DETAILS. ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY
HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682
BRAZILIAN CENTRAL BANK"). DATE RESEARCHED: JULY 05, 2012. |
|
MANUFACTURE, IMPORT AND DISTRIBUTION OF PHARMACEUTICAL PRODUCTS. |
|
IMPORT AND
EXPORT: |
IMPORTS FROM:
|
NOT AVAILABLE. |
EXPORTS TO:
|
NOT AVAILABLE. |
|
MAIN CLIENTS: |
|
|
|
NOT AVAILABLE. |
|
STAFF: |
|
|
|
THE COMPANY HAS: 10 EMPLOYEES |
|
THE SUBJECT IS A NEWLY-ESTABLISHED COMPANY, OPERATING SINCE 2009. SO FAR
IT HAS A CLEAR TRADE HISTORY AND MODEST PAYMENT BEHAVIOUR. THE COMPANY HAS TRADE RELATIONS WITH SOME LOCAL SUPPLIERS BUT UP TO
DATE ONLY SMALL PAYMENTS WERE REPORTED AND THE SUBJECT IS NOT SAID TO BE USER
OF TRADE CREDIT FACILITIES. |
|
MAIN SUPPLIERS: |
|
|
|
NOT AVAILABLE. |
|
PAYMENT HISTORY: |
|
1 SUPPLIERS REPORTED PAYMENTS: |
|
TOTAL AMOUNT: R$ 2.660,00 |
|
|
|
AMOUNT OF INVOICES PAID: 3 |
|
TOTAL OF PROMPT PAYMENTS: 100% |
|
HIGHEST INVOICE: R$ 886,00 |
|
HIGHEST CREDIT: R$ 886,00 |
|
|
|
OUTSTANDING INVOICES DUE WITHIN THE NEXT 30 DAYS: |
|
--------------------------- |
SUPPLIERS: |
INVOICES: |
TOTAL AMOUNT: |
|
DUE WITHIN 30 DAYS |
1 |
1 |
R$ 6.700,80 |
|
BASED ON THE OVERALL DATA AVAILABLE THE SUBJECT MAY BE CONSIDERED FOR
NORMAL BUSINESS COMMITMENTS. CREDIT FACILITIES HOWEVER SHOULD BE GRANTED ON
MODERATE AMOUNTS ONLY DUE TO THE FACT THAT THE COMPANY STARTED ITS OPERATIONS
VERY RECENTLY. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.41 |
|
|
1 |
Rs.86.04 |
|
Euro |
1 |
Rs.68.60 |
INFORMATION DETAILS
|
Report Prepared
by : |
PDT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.